Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

Similar documents
PharmaSUG DS05

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

Traceability Look for the source of your analysis results

Introduction to ADaM and What s new in ADaM

Applying ADaM Principles in Developing a Response Analysis Dataset

Introduction to ADaM standards

ADaM and traceability: Chiesi experience

ADaM for Medical Devices: Extending the Current ADaM Structures

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA

PharmaSUG Paper PO22

An Efficient Solution to Efficacy ADaM Design and Implementation

PharmaSUG2014 Paper DS09

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

Riepilogo e Spazio Q&A

ADaM Compliance Starts with ADaM Specifications

How to write ADaM specifications like a ninja.

PharmaSUG Paper CC02

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

ADaM Implementation Guide Prepared by the CDISC ADaM Team

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

A Taste of SDTM in Real Time

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Creating an ADaM Data Set for Correlation Analyses

Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO

Optimization of the traceability when applying an ADaM Parallel Conversion Method

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

ADaM Implementation Guide Status Update

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

Dealing with changing versions of SDTM and Controlled Terminology (CT)

PharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP

PharmaSUG Paper DS24

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

OpenCDISC Validator 1.4 What s New?

Optimization of the traceability when applying an ADaM Parallel Conversion Method

ADaM Reviewer s Guide Interpretation and Implementation

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Traceability: Some Thoughts and Examples for ADaM Needs

DIA 11234: CDER Data Standards Common Issues Document webinar questions

NCI/CDISC or User Specified CT

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

An Introduction to Visit Window Challenges and Solutions

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

Interpreting CDISC ADaM IG through Users Interpretation

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

Customer oriented CDISC implementation

Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation

Out-of-the-box %definexml

Material covered in the Dec 2014 FDA Binding Guidances

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Deriving Rows in CDISC ADaM BDS Datasets

Updates on CDISC Standards Validation

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

Some Considerations When Designing ADaM Datasets

PhUSE US Connect 2019

Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1

esubmission - Are you really Compliant?

How to handle different versions of SDTM & DEFINE generation in a Single Study?

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Common Programming Errors in CDISC Data

SDTM-ETL 3.0 User Manual and Tutorial

Lex Jansen Octagon Research Solutions, Inc.

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI

Considerations on creation of SDTM datasets for extended studies

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China

Why organizations need MDR system to manage clinical metadata?

PharmaSUG Paper PO21

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Study Data Reviewer s Guide Completion Guideline

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team

Implementing CDISC Using SAS. Full book available for purchase here.

What is high quality study metadata?

Data Integrity through DEFINE.PDF and DEFINE.XML

The application of SDTM in a disease (oncology)-oriented organization

Introduction to Define.xml

Metadata and ADaM.

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

Dataset-XML - A New CDISC Standard

Adding, editing and managing links to external documents in define.xml

CBER STUDY DATA STANDARDS UPDATE

Robust approach to create Define.xml v2.0. Vineet Jain

Reporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1

A Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment

THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC. PhUSE Bethan Thomas DATE PRESENTED BY

Legacy to SDTM Conversion Workshop: Tools and Techniques

CDISC SDTM and ADaM Real World Issues

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Transcription:

Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex Pharmaceuticals Incorporated

Outline Introduction: Traceability in ADaM Programming Introduction: SRCDOM, SRCVAR, and SRCSEQ Triplet Establishing Traceability in Sweat Chloride Analysis Dataset (ADSW) Using SRC Triplet Conclusion Questions/Comments/Thoughts 2

The Key Principles Of ADaM as Stated in ADaM IG v1.0 1. Analysis data should be analysis ready 2. Provide a level of traceability back to the input data 3

Introduction: What is Traceability? Per ADaM IG V1.0, The Property That Enables The Understanding Of Data Linkage And/Or the Relationship Between An Element And Its Predecessor (s) Two Levels Of Traceability 1. Metadata Traceability 2. Data Point Traceability 2010 Vertex Pharmaceuticals Incorporated

Metadata? Metadata: The Information About Data ADaM Programming Specification and Define.xml Provides Meta Data Traceability. 1. Programming Specification 2. Define.xml 2010 Vertex Pharmaceuticals Incorporated

Introduction: Data Point Traceability Enables the Users to Go Directly to the Specific Predecessor (s) Should Be Implemented If Practically Feasible Can Be Very Useful When A Reviewer Is Trying to Trace a Complex Manipulation Path Is Established by Providing Clear Links in the Data to the Data Specific Value Used As Input For Analysis Value May Not Always Practical or Feasible to Provide Data-point Traceability Via Record-identifier Variables From Source Dataset (s) 2010 Vertex Pharmaceuticals Incorporated

How To Build Data Point Traceability? (I) ADaM IG V1.0 recommends numerous ways to build Data Point Traceability. Few Examples: 1. Inclusion of a supportive row or column for traceability even if not required for analysis (VISIT, --SEQ.) 2. PARAMTYP= DERIVED 3. Populating variable DTYPE with derivation method 7

How To Build Data Point Traceability? (II) 4. Populating ANLxxFL to support the accurate selection of records for analysis 5. CRITy/CRITyFL/CRITyFN variables to define and detect the presence of a criterion 6. Combine the Triplet of SRCDOM, SRCVAR, and SRCSEQ with Derived Variables in ADaM IG 1.0 in Page 38 8

Goal to Build Traceability in ADaM Data 1. Facilitate Transparency 2. Build Confidence in Analysis Results 3. Facilitate Programming Validation 4. Speed Up the Overall Review Process from FDA Reviewers 5. Build A Good Relationship with FDA Reviewers 9 2010 Vertex Pharmaceuticals Incorporated

Definition: Using Triplet: SRCDOM, SRCVAR, and SRCSEQ to Build Traceability (I) SRCDOM Source Domain The 2-character identifier of the SDTM domain that relates to AVAL or AVALC. SRCVAR Source Variable The name of the column (in the SDTM domain identified by SRCDOM) that relates to AVAL or AVALC. SRCSEQ Source Sequence Number The sequence number SEQ of the row (in the SDTM domain identified by SRCDOM) that relates to AVAL or AVALC. 2010 Vertex Pharmaceuticals Incorporated

Definition: Using Triplet: SRCDOM, SRCVAR, and SRCSEQ to Build Traceability (II) Per the definition from ADaM IG V1.0 1. SRCDOM should be a SDTM domain. 2. SRCVAR should be a variable from SDTM domain. 3. SRCSEQ should be a SEQ from SDTM domain. 11

Limitation Of SRCDOM, SRCVAR, and SRCSEQ Limitation of the Triplet : One Source SDTM Domain One Source Record One Source Variable Only Direct Copy of Source Value Can NOT Keep Traceability When An Analysis Parameter in ADaM Is Derived from Multiple SDTM Records. 12

Solutions to the Limitation This presentation provides examples of using SRC--- triplet to resolve this limitation by slightly modifying the usage of SRC--- triplet without losing the actual definition. Use Another Method Shown in the Next Slide 13

Another Method: Adding Variable Pair : RLCRIT and RLFACT Use Metadata to Describe the Derivation Rules of the Derived Parameters Add Variables RLCRIT and RLFACT to Connect Derived Records and Their Source Records: RLCRIT - relation criteria that stores data source (ADaM or SDTM data sets) with source variables in order RLFACT - relation factors that stores the values of those source variables in the same order Refer to 1. Zhu, Songhui and Yan, Lin. Methods of Building Traceability for ADaM Data. PharmaSUG 2011 2. Xiangchen (Bob) Cui, Hongyu Liu, and Tathabbai Pakalapati. Examples of Building Traceability in CDISC ADaM Datasets for FDA Submission. SAS Global, April 2012 2010 Vertex Pharmaceuticals Incorporated

Introduction In this presentation, the examples were from efficacy ADaM datasets from Cystic Fibrosis therapeutic area. We will discuss ADSW (Sweat Chloride Analysis Data Set) today. 15

Structure of Sweat Chloride of SDTM.SW Note: Records with even numbers of swseq were from the volume and the records with odd numbers of swseq were used for analysis. 16

Analysis Value of Sweat Chloride (ADSW.AVAL) at An Analysis Visit (AVISIT) in ADaM Per SAP 1. Analysis Value at Each Analysis Visit (AVISIT): Average of Sweat Chloride at Both Left and Right Arms Collected at A Nominal Visit 2. Baseline Analysis Visit: Average of Sweat Chloride from the Pre-dose Scheduled Visits 3. Average On-treatment Sweat Chloride: Average of Sweat Chloride from the On-treatment Scheduled Visits Note: 2 and 3 are the Average of analysis values from 1, i.e. values from ADaM.ADSW, not SDTM.SW. 17

Building Data Point Traceability for These Three Averages in ADSW Create Variable ASWSEQ= Analysis Sequence Number Starting from 1000 to Indicate the Newly Created Records PARAMTYP= DERIVED DTYPE= AVERAGE Populate the Variable SRCDOM, SRCVAR, and SRCSEQ to These Newly Created Records 18

Traceability For Average Sweat Chloride At Both Left And Right Arms At Every Analysis Visit 1. PARAMTYP= DERIVED tells the reviewer these records are derived in ADaM, with sequence numbers above 1000. 2. SRCSEQ=23 for AVISIT= Day 14 suggests that only sweat chloride at left arm is used to populate AVAL, as sweat chloride at right arm is missing. 19 3. SRCSEQ lists sequence numbers, separated by $, of those records in SDTM SW used in deriving AVAL. Hence SRCSEQ is the concatenation of two sequence numbers--- A deviation from IG!

Traceability For Baseline Analysis Visit (I) ASWSEQ = 0.5 more than the sequence number corresponding to the last predose analysis visit (1002+0.5) to be created as a new sorting key in ADSW SRCDOM= ADSW, SRCVAR= AVAL and SRCSEQ= 1001$1002 for AVISIT= Baseline indicating that analysis value (AVAL) is derived, using the AVAL in ADSW, corresponding to sequence numbers 1001 and 1002 (Screening and Day 1 visit, respectively). SRC-triplet above shows another deviation from ADaM IG! 20

Traceability For Average On-Treatment Sweat Chloride Defined as the average of on-treatment analysis values (Day 7, 14, 21, and 28) Its calculation is same as one from Baseline Analysis Visit for traceability with SRCDOM=ADSW and SRCVAR=AVAL. 21

An Example of Traceability For Average On- Treatment Sweat Chloride (I) 22

An Example of Traceability For Average On- Treatment Sweat Chloride (II) How About We Change SRCSEQ= 1005$1006$1007$1008 into More Meaningful SRCSEQ= DAY 7$DAY 14$DAY 21$DAY 28? Better communication and reviewing of the data records 23

An Example of Traceability For Average On- Treatment Sweat Chloride (III) SRCSEQ= DAY 7$DAY 14$DAY 21$DAY 28 SRCSEQ is from VISIT, not ASWSEQ anymore! No sequence numbers are involved! A severe deviation from ADaM IG! 24

An Example of Traceability For Average On- Treatment Sweat Chloride (III) 25

An Example of Traceability For Average On- Treatment Sweat Chloride (I) 26

Snapshot of Traceability For Average On-Treatment Sweat Chloride for Multiple Subjects (I) 27

How Much To Pay For Traceability? No Free Lunch! Write A Clear ADaM Programming Specification Extra SAS Codes 2010 Vertex Pharmaceuticals Incorporated

Write A Clear ADaM Programming Specification Variable Name Variable Label Type Length Controlled Terms or Formats Origin Role Comments Core SRCDOM Source Domain Char 4 Derived Analysis Equal to "ADSW" for derived records (PARAMTYP="DERIVED") and AVISIT is equal to "Baseline" or "Average through Day 28" Equal to "SW" for all other derived records (PARAMTYP ="DERIVED") SRCVAR SRCSEQ Source Variable Source Sequence Number Char 8 Derived Analysis Equal to "AVAL" for derived records (PARAMTYP ="DERIVED") where AVISIT is equal to "Baseline" Equal to "AVAL" for derived records (PARAMTYP ="DERIVED") where AVISIT is equal to "Average through Day 28" Equal to "SWSTRESN" for all other derived records (PARAMTYP="DERIVED") Char 40 Derived Analysis For AVISIT="Baseline" SRCSEQ lists the sequence numbers (SW.SWSEQ) of records that are used to derive the analysis baseline value. Example: if sequence numbers of Screening and Day 1 are 1 and 2 respectively, then SRCSEQ is equal to 1$2 For AVISIT="Average through Day 28" SRCSEQ lists the analysis visits (ADSW.AVISIT) of records that are used to derive the analysis value (average of Day 7, Day 14, Day 21, Day 28). Example: if Day 7, Day 14, Day 21, Day 28 are used to drive the average then SRCSEQ is equal to Day 7$Day 14$Day 21$Day 28 For other derived records SRCSEQ lists the sequence numbers (SW.SWSEQ) of records used to derive the analysis value at each analysis visit. Example: if sequence numbers of SW_CL_L and SW_CL_R at Day 7 are 4 and 5 respectively, then SRCSEQ is equal to 4$5 for AVISIT=DAY 7 Perm Perm Perm 29

Extra SAS Codes for Average On-Treatment: Highlighted in Red Color *** calculate average day 1 through day 28 ( average day 7, 14, 21, and 28 by nominal visit regardless on safety follow up records; proc sort data = sw_cl_m2 out=for_avg; by usubjid swtestcd ADTM visitnum swseq; where visit in ('DAY 7','DAY 14','DAY 21') or (visit='day 28' and SWTPTNUM<=0); run; data average; length DTYPE $20. SRCSEQ $40. SRCDOM $4. SRCVAR $8.; retain total nobs 0 SRCSEQ ''; set for_avg(drop=srcseq); by usubjid SWTESTCD ADTM visitnum; if first.swtestcd then do; total=swstresn; nobs=1; SRCSEQ=strip(visit);end; else do;total=total+swstresn; nobs=nobs+1; SRCSEQ=strip(SRCSEQ) "$" strip(visit); end; if last.swtestcd then do; DTYPE='AVERAGE'; SWSTRESN=total/nobs; SWSEQ=SWSEQ+0.5; SRCDOM='ADSW'; SRCVAR='AVAL'; output; end; run; 30

Is it legal? Is it CDISC ADaM compliant? CDISC ADaM Validation Checks Version 1.2 Rule 180 out of 243 Rules: Only SRCDOM It is illegal! 31

Will We Get Caught Out! We uploaded All ADaM datasets from the study into OpenCDISC Validator for Compliance Checking. No Errors or Warning Messages Reported for SRC-triplet! 32

Will We Get Caught Out! Cont ed OpenCDISC Validator implements total 130 rules from CDISC ADaM Validation Checks Version 1.2 with total 243 rules. OpenCDISC Validator Website: The following is a listing of CDISC ADaM version 1.0 validation rules implemented in OpenCDISC Validator. The rules are based on the validation checks published by CDISC ADaM team. 33

Snapshot of OpenCDISC Validator ADaM Validation Rules from Its Web Site 34

Is it legal? Cont ed Rule 180 Has NOT Been Applied in OpenCDISC Validator Yet. OpenCDISC Validator Can Not Catch It! It seems that we are lucky. 35

The Key Message Here: Should the rule 180 be relaxed into the inclusion of a ADaM domain, in addition to single SDTM domain? Should CDISC ADaM Team Consider to Modify the Rule for SRC-Triplet? 1. SRCDOM: both a SDTM domain and a ADaM domain 2. SRCVAR: both a SDTM Variable and a ADaM Variable 3. SRCSEQ: single SDTM sequence number, multiple SDTM sequence numbers, and other variables 36

Conclusion Incorporating traceability features in ADaM datasets: Helps in effective program validation Speeds up the review process Transparency in submitted analysis data Good Relationship with FDA Applying SRCDOM, SRCVAR, and SRCSEQ to establish traceability is an Art, not a Rocket Science. CDISC ADaM Team Should consider to modify the rule for SRC-Triplet in order to better establishing traceability in ADaM programming! 37

Questions / Comments / Thoughts 38 2010 Vertex Pharmaceuticals Incorporated